Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2014/013953external-prioritypatent/WO2014120981A1/en
Application filed by Gilead Pharmasset LlcfiledCriticalGilead Pharmasset Llc
Publication of CR20150453ApublicationCriticalpatent/CR20150453A/en
Se describen composiciones farmacéuticas que tienen una cantidad eficaz de ledipasvir sustancialmente amorfo y una cantidad eficaz de sofosbuvir sustancialmente cristalino.Pharmaceutical compositions having an effective amount of substantially amorphous ledipasvir and an effective amount of substantially crystalline sofosbuvir are described.
CR20150453A2013-01-312015-08-31
COMBINED FORMULATION OF TWO ANTIVIRAL COMPOUNDS
CR20150453A
(en)
COMPOUNDS OF AMINOPYRIDINE DERIVATIVES AS KINASE INHIBITORS OF THE TAM FAMILY, PHARMACEUTICAL COMPOSITION COMPRISING SAID COMPOUNDS AND THERAPEUTIC USE THEREOF